ErythroMax
N/A
Report date: 2023/02/18 19:46:47
NME
Base Information
Drug NameErythroMax
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMaxcyte Inc
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A